BioCentury
ARTICLE | Company News

Cellzome, GlaxoSmithKline deal

May 21, 2012 7:00 AM UTC

GlaxoSmithKline will acquire the 80.02% of proteomics company Cellzome it does not already own for £61 million ($98 million) in cash. GSK said Cellzome's proteomic mass spectrometry and screening capa...